Does MassHealth / Medicaid cover ketamine therapy or ketamine treatment?

An image of the MassHealth insurance plan logo, to identify it as a mentioned item on the page about if MassHealth / Medicaid covers ketamine therapy or Spravato (esketamine) at Lumin Health.

Latest medical review on: October 21st, 2025. Medically reviewed by Chief Medical Officer Dr. Ben Yudkoff.

Unfortunately, Lumin Health is out of network and cannot accept MassHealth or Medicaid plans to cover ketamine therapy or Spravato (esketamine) for depression and other mental health challenges.

We are grateful for your interest in starting treatment with us and apologize for not being able to accept MassHealth or Medicaid insurance plans.

Does Lumin Health accept MassHealth / Medicaid for Spravato treatment?

Unfortunately, Lumin Health cannot accept Masshealth / Medicaid insurance for our esketamine (Spravato) treatment program.
There is always the option to self-pay though; so please get in touch with us anytime if that is an option for you.

Are there other resources Lumin Health can recommend?

While each institution sets their own insurance acceptance policy, we always recommend that prospective patients reach out to the large hospital networks such as Faulkner Hospital, Massachusetts General Hospital, and McLean.

Frequently asked questions

Article Reviewed by Dr. Benjamin Yudkoff, MD, MA
Dr. Yudkoff is a board-certified psychiatrist who provides the most up-to-date psychiatric care to people managing illnesses that have not satisfactorily resolved with treatment as usual, and in a way which honors principles of autonomy, self-direction, and holistic approaches. He has lectured on spirituality and ketamine therapy, is an Instructor in Psychiatry at Harvard Medical School, and has taught a humanism course to residents of the Harvard Brigham and Women’s Hospital Residency Training Program. Dr. Yudkoff has served as the Medical Director of the Brigham and Women’s Faulkner Hospital and the Medical Director of the Interventional Psychiatric Service (electroconvulsive therapy, ketamine, and esketamine). Dr. Yudkoff has published scientific articles on ketamine and psychopharmacology, and has won several teaching awards from Harvard Medical School students and Brigham and Women’s Psychiatric Residents.